Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dalia L Rotstein

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 18, 2017
A protean disease: The phenotypic range of neuromyelitis optica spectrum disorderDalia L Rotstein
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 25, 2022
Radiologically isolated syndrome and the possibility of preclinical disease activity in aquaporin-4 antibody NMOSDDalia L Rotstein
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 19, 2022
All Bruton's tyrosine kinase inhibitors have similar efficacy and risks: NoDalia L Rotstein
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 23, 2019
Disease-modifying therapies should be stopped in NMOSD patients in remission - NoDalia L Rotstein
Social Science & Medicine (1982)|December 27, 2005
Where does the waiting list begin? A short review of the dynamics and organization of modern waiting listsDalia L Rotstein, David A Alter
Neurology|August 10, 2020
Could wider social networks prevent disability in MS and other neurologic disorders?Dalia L Rotstein, E Ann Yeh
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 11, 2024
Racial and Ethnic Disease Phenotype Differences Are Driven by Genetics: CommentaryKathleen C Munger, Dalia L Rotstein
Multiple Sclerosis and Related Disorders|June 3, 2025
Navigating a paradigm shift in the treatment of CNS demyelinating diseases in a middle-income countryElaine Chew, Dalia L Rotstein, Shanthi Viswanathan
Multiple Sclerosis and Related Disorders|April 25, 2018
Severe aseptic temporal lobe encephalitis on fingolimodDalia L Rotstein, Aditya Bharatha, Daniel Selchen
JAMA Neurology|May 15, 2023
Making Sure Multiple Sclerosis Counts and Is Counted for All-An Update on Multiple Sclerosis Prevalence by Race and Ethnicity in the United StatesDalia L Rotstein, Tirisham V Gyang, Daniel Ontaneda
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 18, 2017
A protean disease: The phenotypic range of neuromyelitis optica spectrum disorderDalia L Rotstein
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 25, 2022
Radiologically isolated syndrome and the possibility of preclinical disease activity in aquaporin-4 antibody NMOSDDalia L Rotstein
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 19, 2022
All Bruton's tyrosine kinase inhibitors have similar efficacy and risks: NoDalia L Rotstein
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 23, 2019
Disease-modifying therapies should be stopped in NMOSD patients in remission - NoDalia L Rotstein
Social Science & Medicine (1982)|December 27, 2005
Where does the waiting list begin? A short review of the dynamics and organization of modern waiting listsDalia L Rotstein, David A Alter
Neurology|August 10, 2020
Could wider social networks prevent disability in MS and other neurologic disorders?Dalia L Rotstein, E Ann Yeh
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 11, 2024
Racial and Ethnic Disease Phenotype Differences Are Driven by Genetics: CommentaryKathleen C Munger, Dalia L Rotstein
Multiple Sclerosis and Related Disorders|June 3, 2025
Navigating a paradigm shift in the treatment of CNS demyelinating diseases in a middle-income countryElaine Chew, Dalia L Rotstein, Shanthi Viswanathan
Multiple Sclerosis and Related Disorders|April 25, 2018
Severe aseptic temporal lobe encephalitis on fingolimodDalia L Rotstein, Aditya Bharatha, Daniel Selchen
JAMA Neurology|May 15, 2023
Making Sure Multiple Sclerosis Counts and Is Counted for All-An Update on Multiple Sclerosis Prevalence by Race and Ethnicity in the United StatesDalia L Rotstein, Tirisham V Gyang, Daniel Ontaneda
Pageof 5